A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
about
Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.Long-term efficacy and safety of botulinum toxin injections in dystonia.Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gaitComparison of botulinum neurotoxin type A formulations in Asia.
P2860
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A new treatment for focal dyst ...... free from complexing proteins
@ast
A new treatment for focal dyst ...... free from complexing proteins
@en
type
label
A new treatment for focal dyst ...... free from complexing proteins
@ast
A new treatment for focal dyst ...... free from complexing proteins
@en
prefLabel
A new treatment for focal dyst ...... free from complexing proteins
@ast
A new treatment for focal dyst ...... free from complexing proteins
@en
P2860
P356
P1476
A new treatment for focal dyst ...... free from complexing proteins
@en
P2093
Joohi Jimenez-Shahed
P2860
P356
10.2147/NDT.S16085
P407
P577
2011-12-23T00:00:00Z